Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 986 across all filing types
Latest filing 2024-01-23 Major Shareholding Noti…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number' and contains the header 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS stands for Regulatory News Service, which is a general regulatory announcement mechanism in the UK. The content details a 'TR-1: Standard form for notification of major holdings' by JPMorgan Chase & Co., indicating a change in significant share ownership (crossing a threshold). While 'Major Shareholding Notification' (MRQ) is a specific category, the presence of the RNS branding and the nature of the filing (a standard regulatory disclosure form) strongly suggests the general regulatory announcement category is the most appropriate fit, especially given the RNS context provided in the document itself. Since this is a standard regulatory disclosure published via RNS, and it fits the description of a regulatory announcement, RNS is the best fit, although MRQ is also highly relevant. Given the explicit RNS context, I will classify it as RNS.
2024-01-23 English
Holding(s) in Company
Regulatory Filings Classification · 98% confidence The document is explicitly labeled with "RNS Number : 1989A" and contains the standard footer information indicating it is provided by RNS, the news service of the London Stock Exchange. The content is a "TR-1: Standard form for notification of major holdings," detailing a change in voting rights held by Barclays PLC. This type of mandatory disclosure regarding significant share ownership changes falls under regulatory reporting. Since there is a specific category for 'Major Shareholding Notification' (MRQ), that is the most precise fit. If MRQ were not available, RNS (General Regulatory Filings) would be the fallback, but MRQ is superior here.
2024-01-18 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 1670A" and contains a standard form titled "TR-1: Standard form for notification of major holdings". This form is used to report changes in significant share ownership (crossing thresholds) by major shareholders, which is a regulatory requirement. This specific type of filing, reporting changes in major shareholdings, aligns directly with the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the content is highly specific to share ownership changes, making MRQ the most precise classification over the general RNS fallback.
2024-01-18 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number' and contains a standard form titled 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership (crossing thresholds) by an entity (Barclays PLC/Barclays Capital Securities Limited) in the issuer (Dechra Pharmaceuticals PLC). This type of filing, reporting changes in major shareholdings, corresponds directly to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2024-01-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is clearly identified by the header 'RNS Number : 0321A' and contains the standard boilerplate text indicating it is provided by RNS, the news service of the London Stock Exchange, approved by the FCA. The content itself is a 'TR-1: Standard form for notification of major holdings' concerning Jefferies Financial Group Inc. and Dechra Pharmaceuticals Plc. This type of filing, which reports changes in significant share ownership thresholds, falls under the category of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2024-01-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number : 0320A' and contains the header 'National Storage Mechanism' and mentions 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The content is a 'TR-1: Standard form for notification of major holdings,' which details changes in voting rights held by an entity (Jefferies Financial Group Inc.). This type of mandatory disclosure regarding significant share ownership changes is a specific regulatory filing. While it relates to shareholding, the specific form (TR-1) and the context of being distributed via RNS strongly point towards a general regulatory announcement rather than a specific category like Director's Dealing (DIRS) or Share Issue (SHA). Given the options, 'Major Shareholding Notification' (MRQ) is the most precise fit for a TR-1 filing detailing changes in major holdings crossing notification thresholds. However, since the document is a direct regulatory filing distributed via RNS, and MRQ is defined as 'Notification of changes in significant share ownership levels (crossing thresholds)', MRQ is the primary classification. If MRQ were not available, RNS would be the fallback.
2024-01-17 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.